BIO Ventures for Global Health (BVGH) is a results-oriented nonprofit organization dedicated to solving global health issues by forming connections between people, resources, and ideas.

 

BVGH was founded in 2004 by the Biotechnology Industry Organization (BIO) with financial and in-kind support from the Bill & Melinda Gates Foundation, the Rockefeller Foundation, and BIO.

 

What We Do

Collaboration

International, cross-sector collaborations are fundamental to the development of new biomedical products. Implementation and maintenance of such partnerships require informed, thoughtful, and proactive alliance management. BVGH recognizes this and employs a unique partnering model to develop meaningful collaborations with clearly defined roles, responsibilities, and deliverables. BVGH’s partnering approach includes:

• Identify Opportunities: Providing your organization with the knowledge, relationships, and recognition required to break into the newly expanding markets of Africa and Latin America
• Find Partners: Connecting your organization to the multifaceted communities of your target region including government agencies, multilateral organizations, and researchers
• Establish Relationships: Identifying meaningful partnership opportunities, facilitating discussions, supporting negotiations, and balancing expectations
• Alliance Management: Providing alliance management support while remaining actively engaged in collaborations post-negotiation.

 

Awareness and Representation

Awareness, trust, and respect among key decision-makers and their constituents smooth entry into a new region. BVGH will advertise and promote your organization and its activities through multiple avenues.

• Awareness: Increasing awareness of your contributions and investments in global health.
• Representation: representing your organization at key global health events.

 

Supporting Research and Development

Biomedical research and biopharmaceutical product development require knowledge, training, infrastructure, technology, and financial support. BVGH expands access to expertise, resources, and funding.

 

Knowledge and reports

BVGH develops custom reports describing the market dynamics, disease landscape, and regulatory environment of the regions of interest to your organization. In addition, BVGH attends and summarizes of discussions, conclusions, and key takeaways from meetings, conferences, and other events held in your organization’s region of interest.

 

Customized Engagement

BVGH can work with your company’s corporate social responsibility department to develop a customized plan to participate in global health activities, as well as facilitate engagement opportunities.

 

Programs

WIPO Re: Search

WIPO Re:Search is led by the World Intellectual Property Organization (WIPO) in partnership with BVGH and several leading pharmaceutical companies. Consortium membership includes academic and nonprofit research institutions, governmental and non-governmental organizations, and budding biotechnology companies committed to addressing the unmet medical needs of the developing world. Our 90+ Members represent 26 countries from six continents, including 18 African institutions.

 

Connecting Researchers and Funders

BVGH has developed a database that summarizes current funding opportunities for infectious disease researchers. The BVGH Funders Database captures research grants, fellowships, scholarships, travel awards, and other funding opportunities. Each opportunity is classified by what disease areas, research stages, and product foci it targets. Funding amount and duration, collaboration requirements, eligibility requirements, geographic restrictions, deadline, and contact point is provided for each opportunity.

 

Nigeria Capacity Building Initiative

BVGH is launching a leadership development and capacity building program, the BVGH Nigeria Capacity Building Initiative (BNCBI), in partnership with the Nigerian National Universities Commission (NUC) and Nigerian research institutions to create a stronger biomedical research and development base in the country. This program will identify individuals from Nigerian institutions and facilitate their hosting at international biopharmaceutical companies. Participating companies will provide the selected individuals with experiences customized to meet the needs of the institution and fellow. Training may include developing advanced biotechnology skills or gaining experience in various phases of the drug development process such as discovery, regulatory, quality control, or clinical development.